as 12-05-2024 4:00pm EST
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.
Founded: | 2016 | Country: | Malaysia |
Employees: | N/A | City: | KUALA LUMPUR |
Market Cap: | 6.1M | IPO Year: | N/A |
Target Price: | N/A | AVG Volume (30 days): | 26.1K |
Analyst Decision: | N/A | Number of Analysts: | N/A |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.68 | EPS Growth: | N/A |
52 Week Low/High: | $1.36 - $19.60 | Next Earning Date: | 11-14-2024 |
Revenue: | $1,354,042 | Revenue Growth: | -5.11% |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
ATPC Breaking Stock News: Dive into ATPC Ticker-Specific Updates for Smart Investing
ACCESSWIRE
7 days ago
ACCESSWIRE
2 months ago
ACCESSWIRE
2 months ago
ACCESSWIRE
2 months ago
ACCESSWIRE
3 months ago
ACCESSWIRE
3 months ago
ACCESSWIRE
3 months ago
GlobeNewswire
3 months ago
The information presented on this page, "ATPC Agape ATP Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.